查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球退烧药市场
市场调查报告书
商品编码
1311877

2023-2030 年全球退烧药市场

Global Antipyretic Drug Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

在预测期内（2023-2030 年），全球退烧药市场预计将以 2.2% 的复合年增长率增长。退烧药是一种药剂，可降低或消除通常由某种炎症引起的发烧。退烧药可使下丘脑抑制前列腺素引起的体温升高。流感的影响各不相同，每年给美国人民的健康造成巨大负担。据美国疾病控制和预防中心（CDC）估计，在 4100 万例发病中，被诊断为流感的约有 900 万例。其中，从 2010 年到 2020 年，每年约有 140,000-710,000 人住院，12,000-52,000 人死亡。

因此，全球对治疗此类流感药物的需求和开发都有大幅增长。例如，2022 年 5 月，强生（韩国）公司在韩国推出了首款粉末状儿童退热止痛药 Children's Tylenol powder 160 mg。儿童泰诺粉可缓解头痛、神经痛、肌肉痛、扭伤痛、痛经、牙痛、关节痛以及感冒引起的发烧和疼痛等多种症状，因此可广泛用于发烧和分娩。因此，市场参与者还致力于推出新剂型的解热镇痛药，这将进一步促进市场增长。

目 录

第 1 章：报告摘要

  • 行业现状分析与增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按细分市场
    • 按地区

第 2 章：市场概述与洞察

  • 报告范围
  • 分析师洞察与当前市场趋势
    • 主要结论
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Sun pharmaceuticals Industries Ltd.
    • 概述
    • 财务分析
    • SWOT 分析
    • 近期发展
  • Johnson and Johnson (J&J)
    • 公司概况
    • 财务分析
    • SWOT 分析
    • 近期发展
  • Pfizer Inc.
    • 概述
    • 财务分析
    • SWOT 分析
    • 近期发展
  • 关键战略分析

第 4 章：市场细分

  • 全球退烧药市场类型
    • 扑热息痛
    • 布洛芬
    • 非甾体抗炎药（NSAID）
    • 其他
  • 按销售类型分類的全球退烧药市场
    • 处方药 (Rx)
    • 非处方药（OTC）
  • 按销售渠道分類的全球退烧药市场
    • 医院药房
    • 药店和零售药店
    • 网上药店
    • 其他（超市）

第 5 章：地区分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • BASF SE
  • CIPLA Ltd
  • Cumberland Pharmaceuticals
  • Divi's Laboratories Limited
  • Dr. Reddy's Laboratories
  • Elfin Drugs Private Limited
  • Glenmark Pharmaceuticals
  • GSK Pharmaceuticals
  • Jordanian Pharmaceutical Manufacturing
  • LUPIN Limited
  • Novartis AG
  • NPS MedicineWise
  • Strides Pharma
  • Torrent Pharmaceuticals Ltd
  • ZYDUS Life
Product Code: OMR2027476

Title: Global Antipyretic Drug Market Size, Share & Trends Analysis Report by Type (Paracetamol, Ibuprofen, Aspirin, NSAID and Others), by Sales Type (Prescription and Over the Counter (OTC)), by Sales Channels (Hospital Pharmacies, Drug Store & Retail Pharmacies, Online Pharmacies, and Others) Forecast Period (2023-2030).

The global antipyretic drug market is anticipated to grow at a CAGR of 2.2% during the forecast period (2023-2030). An antipyretic is a pharmaceutical agent that reduces or eliminates a fever, usually induced by some source of inflammation. Antipyretics cause the hypothalamus to override a prostaglandin-induced increase in temperature. The effects of flu varies it places a substantial burden on the health of people in the US each year. Center for Disease Control and Prevention (CDC) have estimated that out of 41 million incidences of illness, flu was diagnosed to be around 9 million. Among these, approximately 140,000-710,000 hospitalizations, and 12,000-52,000 mortalities have been experiences annually between 2010 and 2020.

Thus, there is a considerable increase in the demand and development of drugs treating such flu across the globe. For instance in May 2022, Johnson & Johnson Korea released the first powder-type children's antipyretic painkiller Children's Tylenol powder 160 mg in Korea. Children's Tylenol powder which gives relief from various effects such as headache, neuralgia, muscle pain, sprain pain, menstrual pain, toothache, and joint pain, as well as fever and pain caused by a cold, so it can be widely used for fever and labor. Hence, the market players are also focusing on introducing new dosage types of Antipyretic Drug solutions which will further bolster the market growth.

Segmental Outlook

The global antipyretic drug market is segmented on type, sales type, and sales channels. Based on the type, the market is sub-segmented into Paracetamol, Ibuprofen, Aspirin, NSAID, and others. Based on the sales type, the market is sub-segmented into prescription and OTC. Further, on the basis of dosage form, the market is sub-segmented into Tablet, Syrup, Injection, and Paste. Based on sales channels, the market is sub-segmented into hospital pharmacies, drug store & retail pharmacies, online pharmacies, and others.

The Over the Counter (OTC) Sub-Segment Is Anticipated To Hold a Considerable Share of the Global Antipyretic Drug Market

Among the industry vertical, the Over the Counter (OTC) is expected to hold a considerable share of the global antipyretic drug market. The segmental growth is attributed to the easy availability of antipyretic drug without doctor's prescription. Owing to which major businesses of the pharmaceutical industry are focusing on investing in effective antipyretic drug solutions for their organizations. For instance, in August 2021, UK government approved combined paracetamol and ibuprofen medicine for general sale a medicine that contains 200mg of ibuprofen and 500mg of paracetamol per tablet. It will become available without any medical prescription for public.

Regional Outlook

The global Antipyretic Drug market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, due to maximum number of COVID-19 cases and deaths, thus, with a plethora of patients reporting fever as a common symptom- the sales of antipyretics rocketed in the year, and others.

The Asia-Pacific Region is expected to grow at a Significant CAGR in the Global Antipyretic Drug Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the growing geriatric population with other forms of chronic and viral illnesses. More than half of the cases of typhoid fever globally were projected to have occurred in India, the implementation of public vaccination has remained low, due to the lack of data regarding the contemporary disease burden.

Market Players Outlook

The major companies serving the Antipyretic Drug market include: Sun Pharmaceuticals Industries Ltd., Pfizer Inc., Johnson and Johnson (J&J), Glenmark Pharmaceuticals, Cipla Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, the Food and Drug Administration (FDA) expanded the approval of Caldolor (ibuprofen injection) to include infants 3 to 6 months of age for the treatment of pain and fever. Previously, the treatment was approved for patients 6 months of age and older.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global antipyretic drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Sun pharmaceuticals Industries Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Johnson and Johnson (J&J)
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Pfizer Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Antipyretic Drug Market By Type
    • 4.1.1. Paracetamol
    • 4.1.2. Ibuprofen
    • 4.1.3. Non-Steroidal Anti-Inflammatory Drugs (NSAID)
    • 4.1.4. Others
  • 4.2. Global Antipyretic Drug Market by Sales Type
    • 4.2.1. Prescription (Rx)
    • 4.2.2. Over the Counter (OTC)
  • 4.3. Global Antipyretic Drug Market by Sales Channel
    • 4.3.1. Hospital Pharmacies
    • 4.3.2. Drug Store & Retail Pharmacies
    • 4.3.3. Online Pharmacies
    • 4.3.4. Others (Supermarkets)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. BASF SE
  • 6.2. CIPLA Ltd
  • 6.3. Cumberland Pharmaceuticals
  • 6.4. Divi's Laboratories Limited
  • 6.5. Dr. Reddy's Laboratories
  • 6.6. Elfin Drugs Private Limited
  • 6.7. Glenmark Pharmaceuticals
  • 6.8. GSK Pharmaceuticals
  • 6.9. Jordanian Pharmaceutical Manufacturing
  • 6.10. LUPIN Limited
  • 6.11. Novartis AG
  • 6.12. NPS MedicineWise
  • 6.13. Strides Pharma
  • 6.14. Torrent Pharmaceuticals Ltd
  • 6.15. ZYDUS Life

LIST OF TABLES

  • 1. GLOBAL ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL PARACETAMOL MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL IBUPROFEN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NSAID MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHER TYPES OF ANTIPYRETIC DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ANTIPYRETIC MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 7. GLOBAL ANTIPYRETIC DRUG BY PRESCRIPTION MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ANTIPYRETIC DRUG BY OVER-THE-COUNTER MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ANTIPYRETIC MARKET RESEARCH AND ANALYSIS BY SALES CHANNEL, 2022-2030 ($ MILLION)
  • 10. GLOBAL ANTIPYRETIC DRUG IN HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL ANTIPYRETIC DRUG IN DRUG STORE AND RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ANTIPYRETIC DRUG IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL ANTIPYRETIC DRUG IN OTHER SALES CHANNELS MARKET RESEARCH AND ANALYSIS REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD ANTIPYRETIC DRUG MARKET RESEARCH AND ANALYSIS BY SALE CHANNELS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANTIPYRETIC DRUG MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL PARACETAMOL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL IBUPROFEN MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NSAID MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER TYPES OF ANTIPYRETIC DRUG MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL ANTIPYRETIC DRUG MARKET SHARE ANALYSIS BY SALES TYPE, 2022-2030 ($ MILLION)
  • 7. GLOBAL ANTIPYRETIC DRUG BY PRESCRIPTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ANTIPYRETIC DRUG BY OVER-THE-COUNTER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ANTIPYRETIC DRUG MARKET SHARE ANALYSIS BY SALES CHANNELS, 2022-2030 ($ MILLION)
  • 10. GLOBAL ANTIPYRETIC DRUG IN HOSPITAL PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL ANTIPYRETIC DRUG IN DRUG STORE AND RETAIL PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ANTIPYRETIC DRUG IN ONLINE PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ANTIPYRETIC DRUG IN OTHER SALES CHANNELS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL ANTIPYRETIC DRUG MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ANTIPYRETIC DRUG MARKET SIZE, 2022-2030 ($ MILLION)